These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 24917602

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [PHARMACOGENETIC MARKERS OF THE EFFECTIVENESS OF TREATMENT OF CHILDREN WITH ATOPIC BRONCHIAL ASTHMA.].
    Balabolkin II, Bulgakova VA.
    Eksp Klin Farmakol; 2016; 79(11):35-40. PubMed ID: 29791107
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis.
    Sin DD, Man J, Sharpe H, Gan WQ, Man SF.
    JAMA; 2004 Jul 21; 292(3):367-76. PubMed ID: 15265853
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP, Lee DK, Menzies D, Lipworth BJ.
    Chest; 2006 Jul 21; 130(1):301-2. PubMed ID: 16840420
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies.
    Albers FC, Price RG, Smith SG, Yancey SW.
    J Allergy Clin Immunol; 2017 Nov 21; 140(5):1464-1466.e4. PubMed ID: 28687231
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma.
    Buhl R, Farmer SG.
    Proc Am Thorac Soc; 2004 Nov 21; 1(2):136-42. PubMed ID: 16113426
    [Abstract] [Full Text] [Related]

  • 15. Black clouds and black boxes: comment on "Long-acting β2-agonist step-off in patients with controlled asthma".
    Chan CM, Shorr AF.
    Arch Intern Med; 2012 Oct 08; 172(18):1375-6. PubMed ID: 22928180
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New combination therapies for asthma.
    Donohue JF, Ohar JA.
    Curr Opin Pulm Med; 2001 Mar 08; 7(2):62-8. PubMed ID: 11224725
    [Abstract] [Full Text] [Related]

  • 20. The prevention of exercise-induced bronchoconstriction: what are the options?
    Anderson SD.
    Expert Rev Respir Med; 2012 Aug 08; 6(4):355-7. PubMed ID: 22971059
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.